
    
      Atezolizumab will be administered at a fixed dose of 1,200 mg by intravenous infusion every
      21 days on an outpatient basis according to the its approved prescribing information.
      Palliative radiation therapy will be delivered concomitant to the 2nd dose of atezolizumab as
      a single fraction of 8 Gy to all eligible metastatic and primary sites.
    
  